Skip to main content
Article thumbnail
Location of Repository

The Spliceosomal Phosphopeptide P140 Controls the Lupus Disease by Interacting with the HSC70 Protein and via a Mechanism Mediated by γδ T Cells

By Nicolas Page, Nicolas Schall, Jean-Marc Strub, Marc Quinternet, Olivier Chaloin, Marion Décossas, Manh Thong Cung, Alain Van Dorsselaer, Jean-Paul Briand and Sylviane Muller


The phosphopeptide P140 issued from the spliceosomal U1-70K snRNP protein is recognized by lupus CD4+ T cells, transiently abolishes T cell reactivity to other spliceosomal peptides in P140-treated MRL/lpr mice, and ameliorates their clinical features. P140 modulates lupus patients' T cell response ex vivo and is currently included in phase IIb clinical trials. Its underlying mechanism of action remains elusive. Here we show that P140 peptide binds a unique cell-surface receptor, the constitutively-expressed chaperone HSC70 protein, known as a presenting-protein. P140 induces apoptosis of activated MRL/lpr CD4+ T cells. In P140-treated mice, it increases peripheral blood lymphocyte apoptosis and decreases B cell, activated T cell, and CD4−CD8−B220+ T cell counts via a specific mechanism strictly depending on γδ T cells. Expression of inflammation-linked genes is rapidly regulated in CD4+ T cells. This work led us to identify a powerful pathway taken by a newly-designed therapeutic peptide to immunomodulate lupus autoimmunity

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1993). 70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host’s anti-tumor immunity.
  2. (2005). A mimic of p21 WAF1/CIP1 Ameliorates Murine Lupus.
  3. (1984). A new force field for molecular mechanical simulation of nucleic acids and proteins.
  4. (1986). Application of molecular dynamics with interproton distance restraints to three-dimensional protein structure determination: a model study of crambin.
  5. (1999). Autoreactive T cells in murine lupus.
  6. (2000). B and T cell immune response to snRNP in lupus mice. Autoreactive CD4 + T cells recognize a T cell epitope located within the conserved RNP consensus sequence of the 70K protein.
  7. (1981). Buildup rates of the nuclear Overhauser effect measured by two-dimensional proton magnetic resonance spectroscopy: implications for studies of protein conformation.
  8. (2005). C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L.
  9. (2007). cd T-cell receptors: functional correlations.
  10. (1983). Coherence transfer by isotropic mixing: application to proton correlation spectroscopy.
  11. (1993). Conformational change of chaperone Hsc70 upon binding to a decapeptide: a circular dichroism study.
  12. (1988). Determination of threedimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations.
  13. (2000). Downregulation of natural killer cells and of cd T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?
  14. (1991). Dynamic light scattering studies of the aggregation of lysozyme under crystallization conditions.
  15. (1998). Expression of B220 on activated T cell blasts recedes apoptosis.
  16. (1995). Fas(CD95)/ FasL interactions required for programmed cell death after T-cell activation.
  17. (1992). Gradient-tailored excitation for singlequantum NMR spectroscopy of aqueous solutions.
  18. (1993). Gradient-tailored water suppression for 1H15N HSQC experiments optimized to retain full sensitivity.
  19. (2000). Heat-induced alterations in the localization of Hsp72 and Hsp73 as measured by indirect immunohistochemistry and immunogold electron microscopy.
  20. (2003). Immunoregulation in the tissues by cd T cells.
  21. (2007). Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus.
  22. (2002). In vivo administration of 15-deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-kB activation.
  23. (1996). Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70.
  24. (1989). Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function.
  25. (2004). Intramolecular T cell spreading in unprimed MRL/lpr mice: Importance of the U1-70K protein sequence 131-151.
  26. (2001). Lymphocyctes T cd in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
  27. (1985). MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy.
  28. (1989). Molecular dynamics simulation techniques for determination of molecular structures from nuclear magnetic resonance data.
  29. (1996). MOLMOL: a program for display and analysis of macromolecular structures.
  30. (2001). Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas lpr and (NZBxNZW)F1 lupus mice.
  31. (2008). PD-1 and its ligands in tolerance and autoimmunity.
  32. (1996). Propagation and regulation of systemic autoimmunity by cd T cells.
  33. (2008). Proteome-wide characterization of sugarbeet seed vigor and its tissue specific expression.
  34. (1997). Pseudopeptide TASP inhibitors of HIV infection block viral entry by binding to a 95-kDa surface protein.
  35. (1991). Reduction of Tcd cell numbers and alteration in subset distribution in systemic lupus erythematosus.
  36. (2001). Regulatory defects in Cbl and mitogenactivated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells.
  37. (1993). Role of cd T cells in murine collagen-induced arthritis.
  38. (2005). Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus.
  39. (2005). Selective modulation of CD4 + T cells from lupus patients by a promiscuous, protective peptide analogue.
  40. (2007). Self/non-self discrimination by human cd T cells: simple solutions for a complex issue?
  41. (1998). Soluble CD16 in the treatment of murine lupus nephritis.
  42. (2008). Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus. Results of an early phase II clinical trial.
  43. (1995). Structures of protein complexes by multidimensional heteronuclear magnetic resonance spectroscopy.
  44. (2003). T cell recognition and therapeutic effects of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr lupus mice.
  45. (2007). T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity.
  46. (1999). The antiHIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans.
  47. (1992). The effect of carboxyl-terminal deletion of thre nuclear transport rate of rat hsc70.
  48. (1994). The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice.
  49. (1995). The Fas death factor.
  50. (1999). The HSC73 Molecular Chaperone: Involvement in MHC Class II Antigen Presentation.
  51. (1990). Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.
  52. (1997). Torsion Angle Dynamics for NMR structure calculation with the new program DYANA.
  53. (1995). Wu ¨thrich K

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.